glp-1 electrolytes and Medications Stack - GLP 1 Support

Ozempic, Rybelsus, Saxenda, Victoza, Wegovy, Mounjaro, Trulicity and Zepbound remain approved by the U.S

Today, we have ever more effective and safer procedures available to patients with obesity, including endoscopic and surgical bariatric options

Enhanced Protein Expression in the Baculovirus/Insect Cell System Using Engineered SUMO Fusions

The Medicare GLP-1 Bridge Program lets eligible Medicare Part D beneficiaries get Wegovy, Zepbound, or Foundayo for a $50 per month medication copay from July 1, 2026 through December 31, 2027

L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial

Klok MD, Jakobsdottir S, Drent ML